Insiders reveal how Boston moved to the forefront of the global fight against deadly diseases
Along with San Francisco, the Boston area was where biotech as an industry had its roots. In the 1980s and 1990s, the industry started gaining traction, with companies moving into Cambridge to set up shop.
The metro area is home to almost 1,000 biotechnology companies -from the earliest startups, to $50 billion companies - academic centers, and life science organizations.
Boston has been home to major developments in how we treat cancer, therapies to tackle rare genetic diseases, and research for cutting-edge technologies like the gene-editing tool CRISPR.
Despite $1 billion+ investments in New York and other efforts to spark the industry, there's something missing there that Boston seems to have. With that in mind, when Business Insider recently visited the city, we asked locals: What's the "special sauce" that makes the Boston area such a hub for drug discovery and development?
Here's what we found.
More from Lydia Ramsey:
- Insiders reveal how Boston moved to the forefront of the global fight against deadly diseases
- There could a better way to protect against the flu, and it has implications for tackling HIV and the common cold (SNY)
- A startup that wants to build an early-warning system for cancer just raised $360 million
- The Senate just confirmed Trump's pick to lead the FDA - here's what that could mean for the agency
- A giant drugmaker just set the strictest price-increase caps of the industry